What are the predictors of response to neoadjuvant ICI? Predictive response markers such as PDL1, TMB, tumor mutational patterns, and smoking status have been extensively studied in advanced NSCLC and have been largely inconclusive [76, 77]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.